FDA Warning Letter — Sato Pharmaceutical Co., Ltd.
The FDA took a Warning Letter action against Sato Pharmaceutical Co., Ltd. on February 2, 2017 (Hachioji, Japan). The action was issued by CDER and concerns drugs products. This facility has 5 or more recent FDA inspections on record.
Action Details
- Facility
- Sato Pharmaceutical Co., Ltd.
- Date
- February 2, 2017
- Fiscal Year
- 2017
- Product Type
- Drugs
- Center
- CDER
- Location
- Hachioji (Japan)